Telomere-related DNA damage response pathways in cancer therapy: prospective targets
Maintaining the structural integrity of genomic chromosomal DNA is an essential role of cellular life and requires two important biological mechanisms: the DNA damage response (DDR) mechanism and telomere protection mechanism at chromosome ends. Because abnormalities in telomeres and cellular DDR re...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_1a159fc4f47f4bf0bb23db8b5f6cac01 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Liting Gu |e author |
700 | 1 | 0 | |a Mingdi Liu |e author |
700 | 1 | 0 | |a Yuning Zhang |e author |
700 | 1 | 0 | |a Honglan Zhou |e author |
700 | 1 | 0 | |a Yishu Wang |e author |
700 | 1 | 0 | |a Zhi-Xiang Xu |e author |
245 | 0 | 0 | |a Telomere-related DNA damage response pathways in cancer therapy: prospective targets |
260 | |b Frontiers Media S.A., |c 2024-06-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2024.1379166 | ||
520 | |a Maintaining the structural integrity of genomic chromosomal DNA is an essential role of cellular life and requires two important biological mechanisms: the DNA damage response (DDR) mechanism and telomere protection mechanism at chromosome ends. Because abnormalities in telomeres and cellular DDR regulation are strongly associated with human aging and cancer, there is a reciprocal regulation of telomeres and cellular DDR. Moreover, several drug treatments for DDR are currently available. This paper reviews the progress in research on the interaction between telomeres and cellular DNA damage repair pathways. The research on the crosstalk between telomere damage and DDR is important for improving the efficacy of tumor treatment. However, further studies are required to confirm this hypothesis. | ||
546 | |a EN | ||
690 | |a alternative lengthening of telomeres | ||
690 | |a cancer | ||
690 | |a DNA damage response | ||
690 | |a telomerase inhibitor | ||
690 | |a telomere | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 15 (2024) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1379166/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/1a159fc4f47f4bf0bb23db8b5f6cac01 |z Connect to this object online. |